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Introduction: Electroencephalogram (EEG) monitoring in patients treated with therapeutic hypothermia after
cardiac arrest may assist in early outcome prediction. Quantitative EEG (qEEG) analysis can reduce the time needed
to review long-term EEG and makes the analysis more objective. In this study, we evaluated the predictive value of
qEEG analysis for neurologic outcome in postanoxic patients.
Methods: In total, 109 patients admitted to the ICU for therapeutic hypothermia after cardiac arrest were included,
divided over a training and a test set. Continuous EEG was recorded during the first 5 days or until ICU discharge.
Neurologic outcomes were based on the best achieved Cerebral Performance Category (CPC) score within
6 months. Of the training set, 27 of 56 patients (48%) and 26 of 53 patients (49%) of the test set achieved good
outcome (CPC 1 to 2). In all patients, a 5 minute epoch was selected each hour, and five qEEG features were
extracted. We introduced the Cerebral Recovery Index (CRI), which combines these features into a single number.
Results: At 24 hours after cardiac arrest, a CRI <0.29 was always associated with poor neurologic outcome, with a
sensitivity of 0.55 (95% confidence interval (CI): 0.32 to 0.76) at a specificity of 1.00 (CI, 0.86 to 1.00) in the test set.
This results in a positive predictive value (PPV) of 1.00 (CI, 0.73 to 1.00) and a negative predictive value (NPV) of 0.71
(CI, 0.53 to 0.85). At the same time, a CRI >0.69 predicted good outcome, with a sensitivity of 0.25 (CI, 0.10 to 0.14)
at a specificity of 1.00 (CI, 0.85 to 1.00) in the test set, and a corresponding NPV of 1.00 (CI, 0.54 to 1.00) and a PPV
of 0.55 (CI, 0.38 to 0.70).
Conclusions: We introduced a combination of qEEG measures expressed in a single number, the CRI, which can
assist in prediction of both poor and good outcomes in postanoxic patients, within 24 hours after cardiac arrest.Introduction
Early prognosis in patients with postanoxic encephalop-
athy after cardiac arrest is limited, especially due to
treatment with mild hypothermia and sedation [1,2]. In
only 34% to 60% of patients treated with hypothermia
after cardiac arrest, will consciousness return [3-5].
Electroencephalography (EEG) monitoring may assist
in early prognosis [6-9]. However, analysis of long-term
EEG registrations is very time-consuming and can be
done only by an experienced electroencephalographer
[10-14]. Furthermore, visual EEG interpretation will al-
ways be partially subjective [11,14].* Correspondence: m.c.cloostermans@utwente.nl
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distribution, and reproduction in any mediumQuantitative EEG (qEEG) analysis can reduce the time
needed to review long-term EEG, and makes the analysis
more objective [12-14]. Additionally, qEEG analysis can
be used to reveal and display trends in EEG patterns over
longer time periods [13]. Thereby it can be used to study
time constants of improvement in the EEG. In a cohort of
30 patients Wennervirta et al. [15] showed that individual
qEEG features, such as the burst-suppression ratio, the re-
sponse entropy, and the state entropy, differed between
good- and poor-outcome groups during the first 24 hours
after cardiac arrest [15]. A response entropy of ≤12.53 and
a subband entropy of ≤11.84 at 24 hours after cardiac ar-
rest both had a sensitivity of 78% and a specificity of 81%
for predicting poor neurologic outcome [15]. These resultsBioMed Central Ltd. This is an open access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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combination of multiple qEEG features integrated as a
single index.
In this study, we analyzed five qEEG features and com-
bined these into the Cerebral Recovery Index (CRI), which
provides a single number that can be used for prognosti-




From June 2010 to February 2013, we monitored all pa-
tients after cardiopulmonary resuscitation who were admit-
ted to the ICU of our hospital (Medisch Spectrum Twente,
Enschede, The Netherlands) for therapeutic hypothermia.
A detailed description of patient-inclusion criteria was
given in [8]. In short, all adult patients (aged >18 years)
who were resuscitated after a cardiac arrest, remained co-
matose, and were admitted to the intensive care unit (ICU)
to receive therapeutic hypothermia (at 33°C, maintained
for 24 hours) were included. Patients with additional
neurologic injuries were excluded. The data of the first pa-
tients (from June 2010 to July 2011), which we also used in
our previous study on the evaluation of predictive value of
visual analysis of the EEG [8], were used as training data to
define qEEG features and optimize parameter settings. The
EEG recordings of the patients included after July 2011
were used as test data, and therefore used only for evalu-
ation. The Institutional Review Board of the Medisch
Spectrum Twente waived the need for informed consent
for EEG monitoring during ICU stay and for the follow-up
after 3 and 6 months by telephone. However, for additional
electrophysiological and clinical evaluation after discharge
from the ICU in the first 60 patients, the local institutional
review board approval and written informed consents were
obtained.
EEG recordings
EEG recordings were started as soon as possible after
the patients’ arrival on the ICU and continued up to
5 days or until discharge from the ICU. For practical
reasons, EEG recordings were not started late at night.
Instead, for patients admitted to the ICU after 11 PM,
the recordings were started the next morning at 7 AM.
Twenty-one silver/silver chloride cup electrodes were
placed on the scalp according to the international 10–20
system. Recordings were made by using a Neurocenter
EEG recording system (Clinical Science Systems,
Voorschoten, The Netherlands). All EEG analyses were
performed offline. EEG data played no role in actual
prognostication of outcome or treatment decisions.
However, the treating physicians were not completely
blinded to the EEG to allow treatment of epileptiform
discharges. Treatment of epileptiform activity was left tothe discretion of the treating physician. Generalized peri-
odic discharges were also interpreted as epileptiform ac-
tivity, and treated with antiepileptic drugs. However, no
treatment protocol existed for treatment, because evi-
dence for effect of treatment is lacking. Therefore, both
the nature and the intensity of treatment differed among
physicians. In general, only moderate levels of antiepi-
leptic drugs were given, and treatment never reached an
intensity to induce burst-suppression EEG; barbiturates
were not used.
Selecting EEG epochs
EEG epochs of 5 minutes were automatically selected
every hour during the first 48 hours after resuscitation
and every 2 hours during the remainder of the registra-
tion. In this selection, the EEG epoch with the least
number of artefacts was chosen, after applying an
artefact-detection algorithm. In this algorithm, EEG data
from 10 minutes before until 10 minutes after the se-
lected time point were assessed. The EEG data of these
20 minutes were divided into 30-second segments. For
each segment, a value for the amount of artefacts was
determined by calculating the number of high-voltage
peaks (movement artefacts), the power ratio between
frequencies inside the EEG range and higher frequencies
(muscle activity), and the number of channels that con-
tains zeros (unstacked wires or loose electrodes). Finally,
the 10 consecutive segments with the lowest summed
artefact values were selected, resulting in a 5-minute
epoch. In EEG registrations with too many artefacts dur-
ing the complete 20 minutes, no epoch was selected for
that selection moment.
Quantitative EEG features
First, all epochs were filtered by a zero-phase 6th order
Butterworth bandpass filter (0.5 to 30 Hz) and trans-
formed to the source derivation. Subsequently, the qEEG
analysis was performed. Five features were used: the
power, the Shannon entropy, the alpha-to-delta ratio, the
regularity (a feature we developed to distinguish burst-
suppression patterns from continuous EEG patterns),
and coherence in the delta band. These features were
motivated by the criteria that a neurologist evaluates
during visual analysis of an EEG. After calculation of the
values of the five qEEG features, all features were nor-
malized between 0 and 1 with a smooth exponential func-
tion, and combined into one overall score, the Cerebral
Recovery Index (CRI).
All qEEG features, except the feature for regularity of the
amplitude, were first calculated per EEG channel and per
10-second segments separately and subsequently averaged
over time and over all channels. The regularity feature was
calculated per channel for the complete 5 minutes at once,
and then averaged over all EEG channels.
AB
Figure 1 Example of two signals with different variance in
amplitude. The signal in (A) shows two short periods with high
amplitude on a zero background; the variance in amplitude in this
signal is relatively high, whereas the signal in (B) has a more-regular or
constant amplitude. The signal in A can be compared with an EEG
showing a burst-suppression pattern, whereas the signal in B can be
compared with an EEG with continuous amplitude. This is expressed in
the regularity index (compare Equation 2 and Figure 2).
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ard deviation (SD) of the EEG was calculated. As the
mean of the signal can be expected to be negligibly small
after filtering, the SD is equivalent to the mean power of
the signal.
Shannon entropy: An analytic technique to quantify
the irregularity of a stochastic signal is entropy. Overall,
entropy describes the complexity or unpredictability of a
signal. In this study, we used the Shannon entropy (HSh),




p xið Þ log2 p xið Þ ð1Þ
where xi is the amplitude of the signal and p(xi) the prob-
ability of its occurrence in the signal segment [16,17]. The
probability density function p(xi) was estimated by using
the histogram method in which the amplitude range of
the signal was linearly divided into bins (from −200 μV to
200 μV, with a bin width of 1 μV.)
Alpha-to-delta ratio: The alpha-to-delta ratio (ADR)
[13,18-20] was calculated as the power ratio between the
alpha (8 to 13 Hz) and delta frequency band (0.5 to
4 Hz). To calculate this power ratio, a power spectral
density was estimated by using Welch’s averaged period-
ogram method by using a Hamming window with a
length of 2 seconds, resulting in a spectral-density esti-
mation with a resolution of 0.5 Hz.
Regularity: To separate burst-suppression patterns
from continuous EEG patterns (with a regular, constant
amplitude), we developed a feature to evaluate the regu-
larity of the amplitude of a signal. In Figure 1, we
present two signals as an example. Figure 1A shows a
signal with a high variance in amplitude, and Figure 1B,
a signal with more regular amplitude. In this technique,
we first squared the signal and applied a moving-average
filter with a window of 0.5 seconds to create a nonnega-
tive smooth signal. The window length of the moving
average was set at 0.5 seconds. A longer window would
average out the differences in activity between subse-
quent bursts and suppressions, whereas a shorter win-
dow length would not average out the individual peaks
within one burst. Subsequently, we sorted the values of
the smoothed signal in “descending” order (see Figure 2).
The normalized standard deviation of this sorted signal
was then calculated as a feature for regularity (REG) in











with N the length of the signal in samples and q the
sorted signal. The nominator calculates the standarddeviation of the sorted signal, which is normalized in a
range between 0 and 1 by the denominator. The REG
value of a signal with constant amplitude is 1, inde-
pendent of the amplitude of the signal. A signal with
relatively low amplitude (suppression) that contains a
short period of higher amplitude (burst) will have a
value close to zero; if there are more or longer bursts,
the REG value will increase. Two examples of this
technique applied on EEG data showing a burst-
suppression pattern and a normal EEG pattern are
given in Figure 2A and B, respectively. Note that the
REG value for the burst-suppression EEG (Figure 2A) is
lower than of the normal continuous EEG (Figure 2B),
indicating that the burst-suppression EEG shows more
spread in amplitude.
Coherence in the delta band: To quantify EEG pat-
terns with an abnormal high synchronization level, the
mean coherence (COH) in the delta band (0.5 to 4 Hz)
between all possible combinations of EEG channels was
implemented. In the calculation of the coherence, we
used a Hanning window with a length of 4 seconds and
an overlap of 2 seconds.Feature combination
Finally, the five qEEG features were combined into a
single number, the Cerebral Recovery Index (CRI). First
the value of each qEEG feature was normalized in the
range from 0 to 1, with 0 corresponding to a pathologic
EEG and 1 corresponding to a physiologic EEG. These
and















































Figure 2 Calculating the regularity of the amplitude (REG) in an EEG showing a burst-suppression pattern (A) and a diffusely slowed
pattern (B). In the top graphs, the raw EEG is shown (black), together with the EEG, after squaring and applying a moving average filter (with a
window of 0.5 seconds) (blue). In the bottom graphs, the signal q is obtained after sorting this smoothed signal in descending order. The
calculated value for the regularity (REG) is the normalized variance of this sorted signal q (compare Equation 2). REG is normalized from 0 to 1,
where a higher value corresponds to a signal with a more regular amplitude, as illustrated.
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schematically displayed in Figure 3 and expressed as:
cSD ¼ 1= 1þ e−2 SD−2:5ð Þ  ð3Þ
dHSh ¼ 1= 1þ e−9 HSh−2:5ð Þ  ð4Þ
dADR ¼ 1= 1þ e−10 ADR−0:5ð Þ  ð5Þ
dREG ¼ 1= 1þ e−10 REG−0:65ð Þ  ð6ÞdCOH ¼ 1= 1þ e10 COH−0:45ð Þ  ð7Þ
The values for the parameters in these expressions
were set after visual inspection of the data of the train-
ing set. We did this for each feature independently,
selecting the data that was most relevant for that specific
feature. For example, for the REG feature we compared
burst-suppression EEGs with normal EEGs showing con-
tinuous activity, while for the SD feature we compared
iso-electric and low-amplitude EEGs with continuous
EEGs.
As the power of an EEG signal is a requirement for a
normal EEG - if there is no power at all, the EEG is flat
Figure 3 Normalized qEEG scores. All five qEEG values are normalized using a smooth sigmoid function (Equations 3, 4, 5, 6, 7), resulting in
score for each feature (annotated with a hat) between 0 and 1. (SD = standard deviation, HSh = Shannon entropy, ADR = alpha to delta ratio,
REG = regularity, COH = coherence).
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score, (cSD ) was multiplied with the mean of the other
four qEEG scores. However due to the sigmoid shape of
the curve for S^D (Equation 3, Figure 3), the value of the
CRI is independent for further changes in power once
the power has reached a certain minimal threshold;
above a mean amplitude of 5 μV the value of the S^D
goes to 1. The resulting expression for the CRI is:




To evaluate the time dependency of the CRI, we intro-
duce a “recovery function”, R(t), expressed as:
R tð Þ ¼ a0 þ a1H t−δð Þ 1−e− t−δð Þ=τ
 
ð9Þ
with H the Heaviside or step function. The constants a0
and a1, delay δ, and time constant τ were estimated by
using the median values of the CRI, for patients with
both good and poor neurologic outcomes.
Outcome assessment
Neurologic outcome assessment was performed at 3 and
6 months after cardiac arrest during a personal meeting
or based on a telephone call, and was always performedby the same author (MT-C). The primary outcome
measure was the best score within 6 months on the 5-
point Glasgow-Pittsburgh CPC scores [21]. Outcome
was dichotomized between “good” and “poor.” A good
outcome was defined as a CPC score of 1 or 2 (no or
moderate neurologic disability), and a poor outcome, as
a CPC score of 3, 4, or 5 (severe disability, coma, or
death).
Statistical analysis
Collected baseline characteristics include age, sex,
weight, location of cardiac arrest (in-hospital versus out-
of-hospital), cause of cardiac arrest, and initial cardiac
rhythm. Information about the administered sedative
(propofol and midazolam) and analgesic (fentanyl and
remifentanyl) drugs and their maximum dose within the
first 24 hours were collected. Statistical analysis for the
variables that were categoric was performed by using a
Pearson χ2 test when no subgroup had an expected
count less than 5, or else a Fisher Exact test was per-
formed. For continuous variables, an independent t test
was applied after confirming that these variables were
normally distributed.
At 12, 18, 24, and 36 hours after cardiac arrest, we de-
termined the area under the curve (AUC) of the receiver
operating characteristic (ROC) curve. Furthermore, we de-
fined at each of these time points two thresholds for the
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predicting poor neurologic outcome, and one correspond-
ing to a 100% specificity for predicting good neurologic
outcome. For each threshold, we calculated the sensitivity,
specificity, positive predictive value (PPV), and negative
predictive value (NPV), and their 95% confidence intervals
(CIs).
Results
In total, 109 consecutive patients were included in the
study. The first 56 patients were used as the training set,
and the remaining 53 patients were included in the test
set. In the training set, 27 (48%) of the 56 patients had
good neurologic outcome (best CPC score ≤2 within
6 months). In the test set, 26 (49%) of the 53 patients had
good neurologic outcome. Additional patient information
of the training set is given in [8]. Table 1 summarizes theTable 1 Comparison of patient characteristics between the pa
neurologic outcome in the test set
Poor neurologic outcome (CPC
Number of patients 27
Number of male 19 (70%)
Age (years) 63 (STD 13)
(range, 27 to 82)






Presumed cause of CA:
Cardiac 17 (63%)
Other origin 6 (22%)
Unknown 4 (15%)
Patients sedated with propofol 27 (100%)
Propofol dose (mg/h/kg) 2.8 (STD 1.0)
(range, 0.9 to 4.8)
Patients sedated with midazolam 8 (30%)
Midazolam dose (μg/kg/hr) 80 (STD 65)
(range, 30 to 214)
Patients treated with fentanyl 18 (67%)
Fentanyl dose (μg/h/kg) 1.5 (STD 0.8)
(range, 0.6 to 3.6)
Patients treated with remifentanil 11 (41%)
Remifentanil dose (μg/h/kg) 4.0 (STD 2.6)
(range, 1.0 to 7.0)
Medication doses are given as the maximum drug dose during the first 24 hours. C
VF, ventricular fibrillation; CA, cardiac arrest.patient characteristics of the test set. Both in the training
and test-set groups, patients with good neurologic out-
come and patients with poor neurologic outcome were se-
dated at the same dosage levels. However, in the test
group, patients with good neurologic outcome received a
slightly higher dose of propofol in comparison to patients
with poor neurologic outcome (Table 1).
Figure 4A and B shows the median CRI values of pa-
tients with good and poor neurologic outcomes and
their corresponding ranges. Figure 4A shows the results
of the training set, and Figure 4B, the test set. Both the
training and test-set patients with good neurologic out-
come have an overall higher CRI than the group of pa-
tients with poor neurologic outcome. We obtained a
reasonable fit of the mean CRI values by using the re-
covery function given by Equation 9. Note that the lar-
gest difference between the fitted recovery curves istients with good neurologic outcome and poor
3–5) Good neurologic outcome (CPC 1–2) P value
26 -
20 (77%) 0.59
58 (STD 11) 0.14










3.4 (STD 1.0) 0.03
(range: 1.3 to 5.4)
6 (23%) 0.59
73 (std 35) 0.84
(range, 33 to 125)
19 (73%) 0.61
1.9 (STD 0.7) 0.13
(range, 0.9 to 2.7)
7 (27%) 0.29
5.5 (STD 3.0) 0.28
(range. 3 to 11)
PC, Cerebral Performance Category; OHCA, out-of-hospital cardiac arrest;
Figure 4 Values of the Cerebral Recovery Index (CRI) for the training (A) and test (B) sets. The green and red dots are the median values
for patients with good and poor neurologic outcome at each time point; the green and red areas are the corresponding ranges. The grey
represents the area where the green and red areas overlap. The fitted recovery functions, R(t) (Equation 9), are given as a solid line. Note that the
largest difference between the fitted CRI curves is present between 12 and 24 hours after cardiac arrest.
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time constant is substantially larger in the patients with
poor neurologic outcome (τ = 14.2 hours in the training
set and τ = 20.2 hours in the test set) in comparison to
the patients with good neurologic outcome (τ = 6.4 in
the training set and τ = 4.5 hours in the test set), indicat-
ing that the EEGs of patients with good neurologic out-
come show a faster improvement.
Tables 2A and B show the results for predicting poor
outcome at 12, 18, 24, and 36 hours after cardiac arrest.
Table 2A shows the results for the training set, andTable 2B, for the test set. At 18 or 24 hours, the CRI per-
forms best. At 24 hours after cardiac arrest, a CRI ≤ 0.29
was always associated with poor neurologic outcome, with
a sensitivity 0.55 (CI, 0.32 to 0.76) at a specificity of 1.00
(CI, 0.86 to 1.00) in the test set. This results in a PPV of
1.00 (CI, 0.73 to 1.00) and a NPV of 0.71 (CI, 0.53–0.85).
At the same time point, a CRI >0.69 can be used for pre-
dicting good outcome, with a sensitivity of 0.25 (CI, 0.10
to 0.14) at a specificity of 1.00 (CI, 0.85 to 1.00) in the test
set, and a corresponding NPV of 1.00 (CI, 0.54 to 1.00)
and a PPV of 0.55 (CI, 0.38 to 0.70).
Table 2 Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the
receiver operating characteristic curve (AUC) for predicting neurologic outcome in the training set (A) and test set (B)
at different time points after cardiac arrest
Time AUC CRI Predicting Sensitivity (CI) Specificity (CI) PPV (CI) NPV (CI)
A. Training set
12 h 0.83 <0.04 Poor outcome 0.27 (0.11–0.50) 1.00 (0.86–1.00) 1.00 (0.54–1.00) 0.60 (0.43–0.75)
>0.90 Good outcome 0.13 (0.03–0.32) 1.00 (0.85–1.00) 1.00 (0.29–1.00) 0.51 (0.35–0.67)
18 h 0.69 <0.19 Poor outcome 0.28 (0.10–0.53) 1.00 (0.85–1.00) 1.00 (0.48–1.00) 0.63 (0.45–0.79)
>0.91 Good outcome 0.05 (0.00–0.22) 1.00 (0.81–1.00) 1.00 (−) 0.46 (0.30–0.63)
24 h 0.87 <0.35 Poor outcome 0.45 (0.23–0.68) 1.00 (0.85–1.00) 1.00 (0.66–1.00) 0.68 (0.49–0.83)
>0.61 Good outcome 0.57 (0.35–0.77) 1.00 (0.83–1.00) 1.00 (0.75–1.00) 0.67 (0.47–0.83)
36 h 0.74 <0.32 Poor outcome 0.28 (0.10–0.53) 1.00 (0.86–1.00) 1.00 (0.48–1.00) 0.65 (0.75–1.00)
>0.91 Good outcome 0.04 (0.00–0.21) 1.00 (0.81–1.00) 1.00 (−) 0.44 (0.28–0.60)
B. Test set
12 h 0.74 <0.02 Poor outcome 0.13 (0.02–0.40) 1.00 (0.83–1.00) 1.00 (0.16–1.00) 0.60 (0.42–0.77)
>1.00 Good outcome 0.00 (0.00–0.17) 1.00 (0.78–1.00) - 0.43 (0.26–0.60)
18 h 0.94 <0.18 Poor outcome 0.59 (0.33–0.82) 1.00 (0.85–1.00) 1.00 (0.69–1.00) 0.76 (0.56–0.90)
>0.57 Good outcome 0.64 (0.41–0.83) 1.00 (0.80–1.00) 1.00 (0.77–1.00) 0.68 (0.46–0.85)
24 h 0.87 <0.29 Poor outcome 0.55 (0.32–0.76) 1.00 (0.86–1.00) 1.00 (0.73–1.00) 0.71 (0.53–0.85)
>0.69 Good outcome 0.25 (0.10–0.47) 1.00 (0.85–1.00) 1.00 (0.54–1.00) 0.55 (0.38–0.70)
36 h 0.84 <0.22 Poor outcome 0.30 (0.12–0.54) 1.00 (0.86–1.00) 1.00 (0.54–1.00) 0.63 (0.46–0.78)
>1.00 Good outcome 0.00 (0.00–0.14) 1.00 (0.83–1.00) - 0.45 (0.30–0.61)
At each time point, we selected two thresholds for the Cerebral Recovery Index (CRI), one corresponding to a 100% specificity for predicting poor neurologic
outcome, and one corresponding to a 100% specificity for predicting good neurologic outcome. In addition, the 95% confidence intervals (CIs) are given.
The threshold of the CRI of >1.00 means that no threshold could be chosen in which good neurologic outcome was predicted correctly in any of the patients
without having any false positives, resulting in a sensitivity of 0.
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Growing evidence suggests that EEG monitoring can
play a significant role in the prediction of neurologic
outcome in patients treated with hypothermia after car-
diac arrest [6-9]. In addition to prognostic parameters
based on visual interpretation of the EEG, we introduce
the Cerebral Recovery Index (CRI), based on five qEEG
features that grade the EEG patterns as observed in pa-
tients after cardiac arrest. This index may assist in the
prediction of neurologic outcome after cardiac arrest.
The advantage of a combined qEEG feature is that it is
very simple to use, and trends in long-term EEG record-
ings can easily be studied, and it still covers more than
one aspect of the EEG. We evaluated the CRI in a train-
ing group of 56 patients and a test group of 53 patients
treated with hypothermia at the ICU after cardiac arrest.
Although many features can be extracted from EEG
data [11,13,18,22], only five were used in this study. The
selection of features was motivated by the EEG charac-
teristics that neurophysiologists evaluate in visual inter-
pretation of the EEG in patients after cardiac arrest.
Subsequently, the features were combined into a single
number: the Cerebral Recovery Index (CRI). For a
proper evaluation of the CRI, we used independent
training and test sets.CRI scores are higher in patients with good outcome
in comparison with patients with poor outcome and can
be used to divide patients into three groups. The first
group (green area in Figure 4) includes only patients
with good neurologic outcome: at 24 hours after cardiac
arrest; 25% of the patients with good neurologic out-
come are in this group. The second group (red area in
Figure 4) includes only patients with poor neurologic
outcome, at 24 hours after cardiac arrest; this group in-
cludes around 55% of all patients with poor neurologic
outcome. The last group (the grey area in Figure 4) in-
cludes patients with good as well as with poor neuro-
logic outcomes. The first and second groups are of the
most interest, because outcome prediction is 100% reli-
able in these patients.
The median values of the CRI of both groups of pa-
tients increased over time. However, the time constant
in the recovery function R(t) of patients with good
neurologic outcome is much smaller than in patients
with poor neurologic outcome. This implies that the
EEGs of patients with good neurologic outcome improve
faster than do those of patients with poor outcome. We
also showed that the CRI at 18 and 24 hours after car-
diac arrest has a higher prognostic value in comparison
to the values at 12 or 36 hours after cardiac arrest. This
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study using visual analyses [8]. Therefore, it is important
to start the EEG registration within the first 24 hours
after cardiac arrest for maximal diagnostic yield. The
CRI threshold for the prediction of poor outcome with a
100% specificity increases from a value of 0.02 to 0.29 in
the period 12-24 hours. This reflects the evolution in
EEG patterns, in agreement with visual inspection. For
instance, an isoelectric EEG in the first hours after car-
diac arrest is observed in patients with both a good and
a poor outcome [6,8]. Such an isoelectric EEG will have
a very low CRI score of almost zero, because the feature
for the amplitude is multiplied with the summed values
of the other four features. In all patients with good
neurologic outcome, isoelectric EEG patterns, if initially
present, will evolve within 24 hours to a burst-suppression
or a continuous EEG pattern [8]. This is reflected by a
CRI score >0.69 at 24 h. The interpretation of the EEG for
prognostication, either quantitative with the CRI or with
visual interpretation, must, therefore, be related to the
time since cardiac arrest. We used 5-minute epochs of
EEG with the fewest artefacts every hour or every 2 hours
to limit the influence of artefacts on the CRI score. As the
EEG patterns of patients after cardiac arrest in general
evolve over hours [8], this interval is sufficient to track
relevant changes.
The thresholds for the CRI slightly varied between the
training and the test sets. For predicting poor outcome
at 24 hours, the threshold decreased from 0.35 to 0.29,
whereas for predicting good outcome at 24 hours, the
threshold increased from 0.61 to 0.69. A larger test set is
necessary to evaluate the thresholds of the CRI before
application in the clinical setting.
Additional improvement might be the reduction of the
irregularity in the border between the grey and green
areas (representing a 100% specificity for predicting
good outcome) in Figure 4. Because changes in the EEG
typically occur slowly and continuously over time, this
border should be smoother. The peaks in the border be-
tween the green and grey areas are therefore nonphysio-
logical. At some points in time, the green and grey areas
even completely overlap. This was caused by high-
amplitude and high-frequency muscle artefacts, resulting
in erroneously high CRI values in some patients with
poor outcome, illustrating that in some patients, our au-
tomated selection of artifact-free EEG epochs was not
sufficiently accurate.
Our method is completely automated, including the
selection of artefact-free data. However, the automatic
selection of artefact-free data is not perfect. An expert is
needed to verify that the selected EEG epoch is indeed
artefact free to assure that the CRI value is reliable.
Therefore, quantitative EEG analysis can reduce the time
needed to review long-term EEG and make interpretationmore objective. However, it is primarily aimed to assist in
the interpretation instead of replacing the visual analysis
of the EEG by an expert neurologist.
The EEG registrations were accessible for the treating
physicians at the ICU to allow treatment of epileptiform
discharges. This could potentially have influenced deci-
sion making. However, the local protocols about patient
treatments were strictly followed. As presently, the EEG
of the first 24 hours is not included in the Dutch guide-
lines, these findings were never used in the decision
making. An absent SSEP during normothermia was a
reason to stop treatment, according to current guide-
lines. Other findings to stop treatment included absence
of both pupillary light and cornea reflexes at day 3 after
cardiac arrest, or an isoelectric or low-voltage EEG at
day 3. In patients with a motor score >4, or in patients
that showed clinical improvement, treatment was never
stopped. The CRI values were calculated offline after in-
clusion of all patients, and were therefore not available
for the treating physicians. The likelihood of a self-
fulfilling prophecy is thus very small. Also, the dichoto-
mization of continuous variables by using a threshold
has its limitations [23]. A larger test set is necessary to
evaluate the thresholds of the CRI before application in
a clinical setting. Evaluation in a larger population may
also result in change of thresholds, which could make it
less suitable for decisions that require 100% accuracy. In
clinical practice, therefore, in the interpretation of the
CRI, the difference of the index from threshold should
also be taken into account.
Another limitation might be that all patients were se-
dated during the hypothermic phase with propofol and,
in some cases, additionally with midazolam in a low
dose, which could have influenced the EEG registrations.
However, both in this and in our previous study [8], we
showed that at group level, patients with good neuro-
logic outcome and patients with poor neurologic out-
come were sedated at the same dosage levels. In the test
group described in this study, patients with good neuro-
logic outcome even received a slightly higher dose of
propofol in comparison to patients with poor neurologic
outcome. Although propofol may have a neuroprotective
effect, this has only been shown in in vitro and in vivo
established experimental models of acute cerebral ische-
mia [24,25]. No clinical data exist that establish neuro-
protection by propofol in humans [26-28]. In our study,
the mean difference in propofol dosage between the
group of poor and good neurologic outcome is small.
The main reason for the difference in propofol dosage
used is probably that the postanoxic encephalopathy in
patients with good neurologic outcome was less severe,
resulting in more muscle activity. Therefore, a higher
dosage of propofol was needed to limit shivering. This
might indicate that the temperature regulation is less
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Furthermore, the improvements in EEG patterns were
already visible within the first 24 hours after cardiac ar-
rest, while patients were still treated with hypothermia
and received sedative drugs. Therefore, it is very unlikely
that the changes in EEG can be explained by the use of
sedative drugs.
Conclusions
We introduce the CRI to quantify and grade continuous
EEG data of patients after cardiac arrest. The CRI can
assist in prediction of both poor and good neurologic
outcome within 24 hours after cardiac arrest.
Key messages
 EEG monitoring in patients treated with therapeutic
hypothermia after cardiac arrest may assist in early
outcome prediction.
 Quantitative EEG analysis can reduce the time
needed to review long-term EEG and makes the ana-
lysis more objective.
 We introduced a combination of five qEEG
measures expressed in a single number, the Cerebral
Recovery Index (CRI), which can assist in prediction
of both poor and good outcome in postanoxic
patients, within 24 hours after cardiac arrest.
 EEGs of patients with good neurologic outcome
improve faster than those of patients with poor
outcome, and the predictive value of the EEG is the
highest in the window from 12 to 24 hours after
cardiac arrest. Therefore, it is important to start the
EEG registration within the first 24 hours after
cardiac arrest for maximal diagnostic yield.
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